{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T21:26:20Z","timestamp":1785446780075,"version":"3.56.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1007\/s12010-024-05060-9","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T10:02:08Z","timestamp":1727776928000},"page":"1055-1072","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Pan-cancer Comprehensive Analysis Identified\u00a0EGFR\u00a0as a Potential Biomarker for Multiple Tumor Types"],"prefix":"10.1007","volume":"197","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0366-5480","authenticated-orcid":false,"given":"Shichao","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muzhi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiTong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RenYi","family":"Geng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,1]]},"reference":[{"key":"5060_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021). Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer Journal for Clinicians, 71, 209\u2013249.","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"5060_CR2","doi-asserted-by":"publisher","first-page":"18518","DOI":"10.1038\/s41598-022-21328-8","volume":"12","author":"Y Wang","year":"2022","unstructured":"Wang, Y., Zhang, Y., Wang, F., Li, T., Song, X., Shi, H., Du, J., Zhang, H., Jing, H., Han, J., Tong, D., & Zhang, J. (2022). Bioinformatics analysis of prognostic value and immunological role of MeCP2 in pan-cancer. Scientific Reports, 12, 18518.","journal-title":"Scientific Reports"},{"key":"5060_CR3","unstructured":"(2020). Pan-cancer analysis of whole genomes. Nature 578, 82\u201393"},{"key":"5060_CR4","doi-asserted-by":"publisher","first-page":"646523","DOI":"10.3389\/fimmu.2021.646523","volume":"12","author":"X Cheng","year":"2021","unstructured":"Cheng, X., Wang, X., Nie, K., Cheng, L., Zhang, Z., Hu, Y., & Peng, W. (2021). Systematic pan-cancer analysis identifies TREM2 as an immunological and prognostic biomarker. Frontiers in Immunology, 12, 646523.","journal-title":"Frontiers in Immunology"},{"key":"5060_CR5","doi-asserted-by":"publisher","first-page":"3958","DOI":"10.1016\/j.ygeno.2020.06.044","volume":"112","author":"X Cui","year":"2020","unstructured":"Cui, X., Zhang, X., Liu, M., Zhao, C., Zhang, N., Ren, Y., Su, C., Zhang, W., Sun, X., He, J., Gao, X., & Yang, J. (2020). A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors. Genomics, 112, 3958\u20133967.","journal-title":"Genomics"},{"key":"5060_CR6","doi-asserted-by":"publisher","first-page":"631067","DOI":"10.3389\/fmolb.2021.631067","volume":"8","author":"Z Lv","year":"2021","unstructured":"Lv, Z., Qi, L., Hu, X., Mo, M., Jiang, H., Fan, B., & Li, Y. (2021). Zic family member 2 (ZIC2): A potential diagnostic and prognostic biomarker for pan-cancer. Frontiers in Molecular Biosciences, 8, 631067.","journal-title":"Frontiers in Molecular Biosciences"},{"key":"5060_CR7","doi-asserted-by":"publisher","first-page":"634617","DOI":"10.3389\/fonc.2021.634617","volume":"11","author":"W Ye","year":"2021","unstructured":"Ye, W., Luo, C., Liu, F., Liu, Z., & Chen, F. (2021). CD96 correlates with immune infiltration and impacts patient prognosis: A pan-cancer analysis. Frontiers in Oncology, 11, 634617.","journal-title":"Frontiers in Oncology"},{"key":"5060_CR8","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/nm.3388","volume":"19","author":"CR Chong","year":"2013","unstructured":"Chong, C. R., & J\u00e4nne, P. A. (2013). The quest to overcome resistance to EGFR-targeted therapies in cancer. Nature Medicine, 19, 1389\u20131400.","journal-title":"Nature Medicine"},{"key":"5060_CR9","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2174\/1568026620666200303123102","volume":"20","author":"DA Sabbah","year":"2020","unstructured":"Sabbah, D. A., Hajjo, R., & Sweidan, K. (2020). Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors. Current Topics in Medicinal Chemistry, 20, 815\u2013834.","journal-title":"Current Topics in Medicinal Chemistry"},{"key":"5060_CR10","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","volume":"366","author":"N Normanno","year":"2006","unstructured":"Normanno, N., De Luca, A., Bianco, C., Strizzi, L., Mancino, M., Maiello, M. R., Carotenuto, A., De Feo, G., Caponigro, F., & Salomon, D. S. (2006). Epidermal growth factor receptor (EGFR) signaling in cancer. Gene, 366, 2\u201316.","journal-title":"Gene"},{"key":"5060_CR11","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3892\/ol.2013.1442","volume":"6","author":"H Guo","year":"2013","unstructured":"Guo, H., Xing, Y., Liu, R., Chen, S., Bian, X., Wang, F., Yang, C., & Wang, X. (2013). 216G\/T (rs712829), a functional variant of the EGFR promoter, is associated with the pleural metastasis of lung adenocarcinoma. Oncology Letters, 6, 693\u2013698.","journal-title":"Oncology Letters"},{"key":"5060_CR12","first-page":"641","volume":"31","author":"E Tsiambas","year":"2017","unstructured":"Tsiambas, E., Mastronikolis, N. S., Lefas, A. Y., Georgiannos, S. N., Ragos, V., Fotiades, P. P., Tsoukalas, N., Kavantzas, N., Karameris, A., Peschos, D., Patsouris, E., & Syrigos, K. (2017). Chromosome 7 multiplication in EGFR-positive lung carcinomas based on tissue microarray analysis. In vivo (Athens, Greece), 31, 641\u2013648.","journal-title":"In vivo (Athens, Greece)"},{"key":"5060_CR13","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1186\/s12859-023-05615-3","volume":"24","author":"C Liao","year":"2023","unstructured":"Liao, C., & Wang, X. (2023). TCGAplot: An R package for integrative pan-cancer analysis and visualization of TCGA multi-omics data. BMC Bioinformatics, 24, 483.","journal-title":"BMC Bioinformatics"},{"key":"5060_CR14","unstructured":"Leung, K. (2004). Cy5.5-Ac-Cys-Z(EGFR:1907), Molecular Imaging and Contrast Agent Database (MICAD), National Center for Biotechnology Information (US), Bethesda (MD)"},{"key":"5060_CR15","doi-asserted-by":"publisher","first-page":"107492","DOI":"10.1016\/j.pharmthera.2020.107492","volume":"208","author":"E Laurini","year":"2020","unstructured":"Laurini, E., Marson, D., Fermeglia, A., Aulic, S., Fermeglia, M., & Pricl, S. (2020). Role of Rad51 and DNA repair in cancer: A molecular perspective. Pharmacology & Therapeutics, 208, 107492.","journal-title":"Pharmacology & Therapeutics"},{"key":"5060_CR16","doi-asserted-by":"publisher","first-page":"10640","DOI":"10.1073\/pnas.1220662110","volume":"110","author":"J Yuan","year":"2013","unstructured":"Yuan, J., & Chen, J. (2013). FIGNL1-containing protein complex is required for efficient homologous recombination repair. Proceedings of the National Academy of Sciences of the United States of America, 110, 10640\u201310645.","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"5060_CR17","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1056\/NEJMra0707704","volume":"358","author":"F Ciardiello","year":"2008","unstructured":"Ciardiello, F., & Tortora, G. (2008). EGFR antagonists in cancer treatment. The New England Journal of Medicine, 358, 1160\u20131174.","journal-title":"The New England Journal of Medicine"},{"key":"5060_CR18","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.cell.2018.03.034","volume":"173","author":"TM Malta","year":"2018","unstructured":"Malta, T. M., Sokolov, A., Gentles, A. J., Burzykowski, T., Poisson, L., Weinstein, J. N., Kami\u0144ska, B., Huelsken, J., Omberg, L., Gevaert, O., Colaprico, A., Czerwi\u0144ska, P., Mazurek, S., Mishra, L., Heyn, H., Krasnitz, A., Godwin, A. K., Lazar, A. J., Stuart, J. M., \u2026 Wiznerowicz, M. (2018). Machine learning identifies stemness features associated with oncogenic dedifferentiation. Cell, 173, 338-354.e315.","journal-title":"Cell"},{"key":"5060_CR19","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.cels.2018.03.003","volume":"6","author":"FX Schaub","year":"2018","unstructured":"Schaub, F. X., Dhankani, V., Berger, A. C., Trivedi, M., Richardson, A. B., Shaw, R., Zhao, W., Zhang, X., Ventura, A., Liu, Y., Ayer, D. E., Hurlin, P. J., Cherniack, A. D., Eisenman, R. N., Bernard, B., & Grandori, C. (2018). Pan-cancer alterations of the MYC oncogene and its proximal network across the Cancer Genome Atlas. Cell Systems, 6, 282-300.e282.","journal-title":"Cell Systems"},{"key":"5060_CR20","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.celrep.2018.03.046","volume":"23","author":"GP Way","year":"2018","unstructured":"Way, G. P., Sanchez-Vega, F., La, K., Armenia, J., Chatila, W. K., Luna, A., Sander, C., Cherniack, A. D., Mina, M., Ciriello, G., Schultz, N., Sanchez, Y., & Greene, C. S. (2018). Machine learning detects pan-cancer Ras pathway activation in The Cancer Genome Atlas. Cell Reports, 23, 172-180.e173.","journal-title":"Cell Reports"},{"key":"5060_CR21","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1038\/ng.2764","volume":"45","author":"JN Weinstein","year":"2013","unstructured":"Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013). The Cancer Genome Atlas Pan-Cancer analysis project. Nature Genetics, 45, 1113\u20131120.","journal-title":"Nature Genetics"},{"key":"5060_CR22","unstructured":"(2013). The Genotype-Tissue Expression (GTEx) project. Nature Genetics 45, 580\u2013585"},{"key":"5060_CR23","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1158\/2159-8290.CD-12-0095","volume":"2","author":"E Cerami","year":"2012","unstructured":"Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., Antipin, Y., Reva, B., Goldberg, A. P., Sander, C., & Schultz, N. (2012). The cBio cancer genomics portal: An open platform for exploring multidimensional cancer genomics data. Cancer Discovery, 2, 401\u2013404.","journal-title":"Cancer Discovery"},{"key":"5060_CR24","doi-asserted-by":"publisher","first-page":"W556","DOI":"10.1093\/nar\/gkz430","volume":"47","author":"Z Tang","year":"2019","unstructured":"Tang, Z., Kang, B., Li, C., Chen, T., & Zhang, Z. (2019). GEPIA2: An enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Research, 47, W556-w560.","journal-title":"Nucleic Acids Research"},{"key":"5060_CR25","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1016\/j.ygeno.2020.07.026","volume":"112","author":"W Hong","year":"2020","unstructured":"Hong, W., Gu, Y., Guan, R., Xie, D., Zhou, H., & Yu, M. (2020). Pan-cancer analysis of the CASP gene family in relation to survival, tumor-infiltrating immune cells and therapeutic targets. Genomics, 112, 4304\u20134315.","journal-title":"Genomics"},{"key":"5060_CR26","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1126\/science.1099314","volume":"304","author":"JG Paez","year":"2004","unstructured":"Paez, J. G., J\u00e4nne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., Naoki, K., Sasaki, H., Fujii, Y., Eck, M. J., Sellers, W. R., Johnson, B. E., & Meyerson, M. (2004). EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science (New York, N.Y.), 304, 1497\u20131500.","journal-title":"Science (New York, N.Y.)"},{"key":"5060_CR27","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.2174\/1389557516666160321114917","volume":"16","author":"D Singh","year":"2016","unstructured":"Singh, D., Attri, B. K., Gill, R. K., & Bariwal, J. (2016). Review on EGFR inhibitors: Critical updates. Mini Reviews in Medicinal Chemistry, 16, 1134\u20131166.","journal-title":"Mini Reviews in Medicinal Chemistry"},{"key":"5060_CR28","doi-asserted-by":"publisher","first-page":"2237","DOI":"10.1200\/JCO.2003.10.038","volume":"21","author":"M Fukuoka","year":"2003","unstructured":"Fukuoka, M., Yano, S., Giaccone, G., Tamura, T., Nakagawa, K., Douillard, J. Y., Nishiwaki, Y., Vansteenkiste, J., Kudoh, S., Rischin, D., Eek, R., Horai, T., Noda, K., Takata, I., Smit, E., Averbuch, S., Macleod, A., Feyereislova, A., Dong, R. P., & Baselga, J. (2003). Multi-institutional randomized phase II trial of gefitinib for previously treated patients with advanced non-small-cell lung cancer (The IDEAL 1 Trial) [corrected]. Journal of Clinical Oncology\u202f: Official Journal of the American Society of Clinical Oncology, 21, 2237\u20132246.","journal-title":"Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology"},{"key":"5060_CR29","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1056\/NEJMoa040938","volume":"350","author":"TJ Lynch","year":"2004","unstructured":"Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., Louis, D. N., Christiani, D. C., Settleman, J., & Haber, D. A. (2004). Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib. The New England Journal of Medicine, 350, 2129\u20132139.","journal-title":"The New England Journal of Medicine"},{"key":"5060_CR30","doi-asserted-by":"publisher","first-page":"e73","DOI":"10.1371\/journal.pmed.0020073","volume":"2","author":"W Pao","year":"2005","unstructured":"Pao, W., Miller, V. A., Politi, K. A., Riely, G. J., Somwar, R., Zakowski, M. F., Kris, M. G., & Varmus, H. (2005). Acquired resistance of lung adenocarcinomas to gefitinib or erlotinib is associated with a second mutation in the EGFR kinase domain. PLoS Medicine, 2, e73.","journal-title":"PLoS Medicine"},{"key":"5060_CR31","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1177\/0193841X211053937","volume":"45","author":"A Kolar","year":"2021","unstructured":"Kolar, A., & Steiner, P. M. (2021). The role of sample size to attain statistically comparable groups - a required data preprocessing step to estimate causal effects with observational data. Evaluation Review, 45, 195\u2013227.","journal-title":"Evaluation Review"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05060-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-024-05060-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05060-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T17:06:03Z","timestamp":1739466363000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-024-05060-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,1]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["5060"],"URL":"https:\/\/doi.org\/10.1007\/s12010-024-05060-9","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"value":"0273-2289","type":"print"},{"value":"1559-0291","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,1]]},"assertion":[{"value":"19 September 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The article utilizes data from public databases; hence, it does not involve any in vivo experiments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All the authors agreed to participate in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All the authors agreed to publish the experimental study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}